Search results
Biotech Firm Targets Big Pharma With Drug-Tweak Patent Strategy
Bloomberg Law· 6 hours agoA neuroscientist-led startup is borrowing a page from Big Pharma’s playbook, taking advantage of drug-approval shortcuts while securing advancements in psychiatric treatments—including ...